© 2019 AbbVie Inc.
For adults with moderate to severe rheumatoid arthritis (RA) for whom methotrexate did not work well.



RINVOQ goes the distance to significantly help improve symptoms, and for some, even reduce fatigue.
Results that speak loudly.
RINVOQ helps:
Tame joint pain, swelling, and stiffness
Significantly reduce fatigue in some patients
Stop further joint damage
Improve physical function






Spark the conversation
Be prepared to talk to your doctor about RINVOQ with these conversation starters.



Pay as little as $5 a month
The RINVOQ Complete Savings Card may help commercially insured patients pay as little as $5 a month* for RINVOQ.



Stay in the know
Sign up for the latest updates and information from RINVOQ.



Share your RINVOQ story
Share your experience with RINVOQ to help inform and inspire others. To participate, please email us at info@SPEAKnetwork.net or call 877-861-6180.



Find a rheumatologist
Partner with a rheumatologist and ask them about RINVOQ and the possibility of significantly reducing your RA symptoms.
*Terms and Conditions apply. This benefit covers RINVOQ™ (upadacitinib) alone or for RINVOQ plus one of the following medications: methotrexate, leflunomide (Arava®), or hydroxychloroquine (Plaquenil®). Eligibility: Available to patients with commercial prescription insurance coverage for RINVOQ who meet eligibility criteria. Co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the RINVOQ Complete Savings Card and patient must call RINVOQ Complete at 1.800.2RINVOQ to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the RINVOQ Complete program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. Patients who are members of insurance plans that claim to reduce or eliminate their patients' out of pocket co-pay, co-insurance, or deductible obligations for certain prescription drugs based upon the availability of, or patient's enrollment in, manufacturer sponsored co-pay assistance for such drugs (often termed "maximizer" programs) will have an annual maximum program benefit of $6,000.00 per calendar year. This assistance offer is not health insurance. To learn about AbbVie’s privacy practices and your privacy choices, visit www.abbvie.com/privacy.html
Arava and Plaquenil are registered trademarks of their respective owners.